ANI Pharmaceuticals, Inc. (ANIP) is a publicly traded Healthcare sector company. As of July 13, 2026, ANIP trades at $80.57 with a market cap of $1.87B and a P/E ratio of 19.98. ANIP moved -2.14% today. Year to date, ANIP is +3.34%; over the trailing twelve months it is +24.16%. Its 52-week range spans $52.50 to $99.50. Analyst consensus is strong buy with an average price target of $114.00. Rallies surfaces ANIP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ANIP insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $80.57 |
| Market Cap | $1.87B |
| P/E Ratio | 19.98 |
| EPS | $4.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $99.50 |
| 52-Week Low | $52.50 |
| Volume | 88.09K |
| Avg Volume | 0 |
| Revenue (TTM) | $923.71M |
| Net Income | $92.15M |
| Gross Margin | 0.00% |
6 analysts cover ANIP: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $114.00.